Cardiac amyloidosis other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Cardiac amyloidosis}} {{CMG}}{{AE}}{{Sab}} ==Overview== ==Other Diagnostic Studies== ==References== {{Reflist|2}}")
 
 
Line 4: Line 4:


==Overview==
==Overview==
Reduced [[heart rate variability]] due to [[autonomic dysfunction]] can be observed on [[Holter monitor|Holter monitoring]]. This lack of [[Heart rate variability|variability in the heart rate]] has been shown to be a more consistent predictive parameter of short-term [[mortality]] in [[Patient|patients]] with [[AL type amyloidosis]] with [[Heart|cardiac]] involvement as compared to those with [[AA type amyloidosis]].


==Other Diagnostic Studies==
==Other Diagnostic Studies==
===Holter Monitoring===
* Reduced [[heart rate variability]] due to [[autonomic dysfunction]] can be observed on [[Holter monitor|Holter monitoring]].
* Reduced [[heart rate variability]] is a predictor of 1-year [[mortality]] in cardiac amyloidosis [[Patient|patients]].<ref name="pmid11785998">{{cite journal |author=Reyners AK, Hazenberg BP, Reitsma WD, Smit AJ |title=Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis |journal=[[European Heart Journal]] |volume=23 |issue=2 |pages=157–61 |year=2002 |month=January |pmid=11785998 |doi=10.1053/euhj.2001.2972 |url=}}</ref>
* This lack of [[Heart rate variability|variability in the heart rate]] has been shown to be a more consistent predictive parameter of short-term [[mortality]] in [[Patient|patients]] with [[AL type amyloidosis]] with [[Heart|cardiac]] involvement as compared to those with [[AA type amyloidosis]].


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 21:53, 30 October 2019

Cardiac amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiac Amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac amyloidosis other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac amyloidosis other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac amyloidosis other diagnostic studies

CDC onCardiac amyloidosis other diagnostic studies

Cardiac amyloidosis other diagnostic studies in the news

Blogs on Cardiac amyloidosis other diagnostic studies

Directions to Hospitals Treating Cardiac amyloidosis

Risk calculators and risk factors for Cardiac amyloidosis other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]

Overview

Reduced heart rate variability due to autonomic dysfunction can be observed on Holter monitoring. This lack of variability in the heart rate has been shown to be a more consistent predictive parameter of short-term mortality in patients with AL type amyloidosis with cardiac involvement as compared to those with AA type amyloidosis.

Other Diagnostic Studies

Holter Monitoring

References

  1. Reyners AK, Hazenberg BP, Reitsma WD, Smit AJ (2002). "Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis". European Heart Journal. 23 (2): 157–61. doi:10.1053/euhj.2001.2972. PMID 11785998. Unknown parameter |month= ignored (help)